Emergent BioSolutions Inc. (EBS) Reports Material Event to SEC
Emergent BioSolutions Inc. (NASDAQ:EBS) filed a Form 8-K with the Securities and Exchange Commission on January 14, 2026, disclosing a material event. Emergent BioSolutions Inc.'s…
Read more
